Use of Trypsin in the Treatment of Experimental Coronary Thrombosis | Zendy

CARL R. CONRAD | Zendy; Arthur F. Geis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Trypsin in the Treatment of Experimental Coronary Thrombosis

Author(s) -

CARL R. CONRAD,

Arthur F. Geis

Publication year - 1958

Publication title -

circulation research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.899

H-Index - 336

eISSN - 1524-4571

pISSN - 0009-7330

DOI - 10.1161/01.res.6.3.352

Subject(s) - trypsin , myocardial infarction , cardiology , thrombin , thrombosis , medicine , coronary thrombosis , enzyme , platelet , chemistry , biochemistry

A method for the production of experimental coronary thrombosis in dogs by the injection of thrombin into the anterior descending branch of the left coronary artery is presented. The clot-dissolving properties of trypsin in the form of Tryptar and Enzar were evaluated. The effect of trypsin was also studied in relation to changes in the clotting mechanism of the blood for the purpose of determining tolerated doses. Regardless of amounts of enzyme or time of administration, there was no evidence to indicate prevention of myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research